| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 07/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 08/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 03/11/2004 |
| Director/Board Member | 52 | 31/01/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 31/12/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| -2.25% | -0.47% | +72.43% | +119.36% | 1,052B | |
| -0.66% | +0.43% | +49.01% | +50.11% | 627B | |
| -0.54% | +1.39% | +21.88% | +63.83% | 441B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 349B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 287B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 241B | |
| -0.63% | +1.04% | +43.03% | +59.10% | 224B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 202B | |
| +0.16% | +3.87% | +16.25% | +73.27% | 172B | |
| Average | -0.36% | +0.43% | +28.73% | +42.79% | 399.46B | |
| Weighted average by Cap. | -0.09% | +0.32% | +41.31% | +62.03% |
Employees
18
Sector
Pharmaceuticals
